Welcome to LookChem.com Sign In|Join Free

CAS

  • or

305801-19-8

Post Buying Request

305801-19-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

305801-19-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 305801-19-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,5,8,0 and 1 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 305801-19:
(8*3)+(7*0)+(6*5)+(5*8)+(4*0)+(3*1)+(2*1)+(1*9)=108
108 % 10 = 8
So 305801-19-8 is a valid CAS Registry Number.

305801-19-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-chloro-6,7-dimethoxyquinoline-3-carboxylic acid

1.2 Other means of identification

Product number -
Other names 4-chloro-6,7-dimethoxy-3-quinolinecarboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:305801-19-8 SDS

305801-19-8Downstream Products

305801-19-8Relevant articles and documents

ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE 1 INHIBITORS,COMPOSITIONS AND USES THEREOF

-

Page/Page column 51-52, (2021/10/15)

The present invention relates to compounds of Formula (I), methods of using the compounds as ENPP1 inhibitors, and pharmaceutical compositions comprising such compounds.The compounds are useful in treating cancers and infectious diseases.

Quinoline derivatives as inhibitors of MEK enzymes

-

Page/Page column 25-26, (2008/06/13)

A compound formula (I) or a pharmaceutically acceptable salt thereof, for use in the manufacture of a medicament for inhibition of MEK in a mammal with a MEK mediated disease wherein: n is 0-1; Y is selected from —NH—, —O—, —S—, or —NR7— where

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 305801-19-8